Skip to content

Cellanome

3 viewers · 30d

Total raised

$75.9M

1 filing since 2025 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $75.9M
ROUNDS
1
INVESTORS
22
FOUNDED
N/A
HQ
Foster City, CA
SECTOR
Biotech
EMPLOYEES
N/A
30D VIEWERS
3

AI overview

Updated

Cellanome is a Foster City, California life-science tools company building a multimodal single-cell analysis platform. Its technology pairs time-lapse live-cell imaging with single-cell molecular profiling such as transcriptomics, so researchers can watch cells behave over time and then connect that behavior to their molecular state. The company was founded by veterans of Illumina and Seer, with Omead Ostadan as CEO, Mostafa Ronaghi as cofounder and Jay Flatley as chairman. It sells into oncology, immunology, neuroscience, and aging and metabolic disease research.

What sets it apart

Proprietary CellCage micro-environments keep individual cells or small ensembles in a biocompatible enclosure through culture, imaging, perturbation and sequencing, so dynamic behavior and downstream molecular readouts come from the same cells in one integrated workflow rather than from separate static assays.

Funding history

1 round
Equity+1Dec 23, 2025
Form D
+$75.9M$75.9M total

Latest SEC filings

via EDGAR · CIK 0001886462
Form D · Dec 23, 2025View on EDGAR

Products

1 tracked

R3200 Platform

Life science research instrument

A fully integrated system combining instrumentation, consumables and software that runs complex single-cell assays end to end, capturing fluorescent live-cell imaging and transcriptomic readouts from cells held in CellCage enclosures.

  • CellCage biocompatible micro-environments that preserve native cell morphology
  • Fluorescent live-cell time-lapse imaging paired with single-cell transcriptomics
  • Integrated instrument, consumables and software in one workflow
  • Scales from single cells to complex multi-cell ensembles

Links

WebsiteLinkedInSEC EDGAR filings